ClinicalTrials.gg
RecruitingNCT05329129Updated Oct 28, 2026

OssDsign® Spine Registry Study ("Propel")

An observational study in Degenerative Disc Disease and Spinal Stenosis, sponsored by OssDsign. Recruiting at 16 sites in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by OssDsign · Observational

From the registry’s dates

  • Started Mar 2022; still recruiting 4 years 7 months later.
Updated Oct 28, 2026Site recruiting status changedStudy contact changed+1 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
450
Ages
21 Years and older
Sex
All
01

Study summary

The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.

Read the detailed description

This multi-center study (up to 25 US study sites) is a post market, prospective, observational spine fusion registry. The outcomes of patients undergoing spine fusion with OssDsign® bone grafts will be documented and evaluated for the purposes of post market clinical follow up as part of OssDsign® post market surveillance activities. The length of study duration and number to be recruited is open-ended but initially a target of 750 subjects will be recruited and followed up for a period of 24 months ± 90 days after their index surgery in which an OssDsign® bone graft has been implanted.

02

Conditions studied

  • Degenerative Disc Disease
  • Spinal Stenosis

Keywords

  • Synthetic bone grafts
  • Degenerative Disc Disease
  • Bone fusion
03

In context

Intervertebral Disc Degeneration

462 studies on the registry are indexed under Intervertebral Disc Degeneration; 100 are open to participants now.

This study's planned enrollment of 450 is above the median of 119 across 170 observational studies indexed under Intervertebral Disc Degeneration.

Browse Intervertebral Disc Degeneration studies →

Lead sponsor

OssDsign is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients diagnosed with as a candidate for spinal fusion surgery

Eligibility criteria

  • The patient has been diagnosed as a candidate for spinal fusion surgery for which the surgeon has decided an OssDsign® bone graft is appropriate.
  • The patient is ≥21 years old.
  • The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written
  • The patient is willing and able to participate in post- operative clinical and radiographic follow up evaluations for 2 years.

Exclusion Criteria:

  • Patients not meeting all of the inclusion criteria
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
450 participants (estimated)
Patient registry
No

Interventions

  • DeviceOssDsign® Catalyst

    An osteoconductive, resorbable, porous, 100 % nano synthetic calcium phosphate bone void filler

06

What researchers measure

Primary outcomes

  1. Rate of bone fusion

    Assessment of the rate of bone fusion via Computerized Tomography (CT)/x-ray based on evidence of continuous bone bridging from the superior to the inferior vertebral body at the target level.

    Time frame: 12 months ± 60 days post-operative examination

Secondary outcomes

  1. Quality of Life Questionnaire: Oswestry Disability Index

    A questionnaire used to measure a patient's permanent functional disability scored 0-4, (no disability) to 35-50, (completely disabled).

    Time frame: Up to 4 months, 6, 12 and 24 months

  2. Quality of Life Questionnaire: Neck Disability Index (NDI)

    A self-reported questionnaire to determine how pain affects everyday life and assess the level of disability and scored from 0 (no disability) to 50 (complete disability).

    Time frame: Up to 4 months, 6, 12 and 24 months

  3. Quality of Life Questionnaire: Visual Analog Scale (VAS)

    A self rated pain scale from 0 (no pain) to 10 (worst imaginable pain)

    Time frame: Up to 4 months, 6, 12 and 24 months

  4. Quality of Life Questionnaire: Short Form 36 (SF-36)

    A Questionnaire used to measure the impact of clinical and social interventions using eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability

    Time frame: Up to 4 months, 6, 12 and 24 months

  5. Neurological Function

    All subjects will be assessed for sensory, reflex, and muscle strength (motor) by the clinician

    Time frame: Up to 4 months, 6, 12 and 24 months

  6. Presence of bone fusion

    All subjects will undergo x-ray evaluation to include AP and neutral lateral views pre-operatively. At post-operative visits AP and neutral lateral x-rays, plus flexion and extension x-rays (if standard care) taken with the subject standing up and/or a CT scan taken.

    Time frame: 6, 12 and 24 months

  7. Safety review of device related AE's

    Review of Adverse Events

    Time frame: Throughout study, 24 months

07

Study locations

8 of 16 sites recruiting
  • Community Health Partners Neuroscience
    Fresno, California 93720, United States
    Recruiting
  • Memorial Orthopaedic Surgical Group
    Long Beach, California 90806, United States
    Recruiting
    • Clinical Research Asociate · Contactnanettemsoto@gmail.com · 714-858-8535
    • Philip S Yuan, MD · Principal investigator
  • San Diego Neurosurgery
    San Diego, California 92024, United States
    Terminated

    Not enrolling at this site.

  • Orthopedic Associates of Hartford
    Hartford, Connecticut 06102, United States
    Recruiting
  • Central Connecticut Neurosurgery and Spine
    New Britian, Connecticut 06051, United States
    Recruiting
  • Yale Center for Clinical Investigation, Yale School of Medicine
    New Haven, Connecticut 06519, United States
    Active, not recruiting

    Not enrolling at this site.

  • Minimally Invasive Spine Center of South Florida
    Miami, Florida 33133, United States
    Recruiting
  • Foundation for Orthopaedic Research and Education
    Tampa, Florida 33607, United States
    Active, not recruiting

    Not enrolling at this site.

  • Northeast Georgia Medical Center
    Gainesville, Georgia 30501, United States
    Active, not recruiting

    Not enrolling at this site.

  • Carle Foundation Hospital, NeuroScience Institute
    Urbana, Illinois 61801, United States
    Completed

    Not enrolling at this site.

  • Orthopaedic Institute of Western Kentucky
    Paducah, Kentucky 42001, United States
    Completed

    Not enrolling at this site.

  • OrthoBethesda Research Foundation
    Bethesda, Maryland 20817, United States
    Completed

    Not enrolling at this site.

  • Michigan Orthopaedic Surgeons
    Southfield, Michigan 48033, United States
    Recruiting
  • Twin Cities Orthopedics
    Edina, Minnesota 55435, United States
    Active, not recruiting

    Not enrolling at this site.

  • University Orthopedics Center
    State College, Pennsylvania 16801, United States
    Recruiting
    • Jill Fremberg, RN · Contactjfremberg@ouc.com · 814-272-3751
    • James Burke, M.D., PhD., FAANS · Principal investigator
  • Texas Spine Consultants
    Addison, Texas 75001, United States
    Recruiting
    • Kimberly Myers · Contacthaariss@ilyas.com · 214-370-3535
    • Haariss S Ilyas, MD · Principal investigator
08

Updates

1 registry update since Sep 25, 2026
Sites
1 site added. 5 sites changed recruiting status (2 now recruiting, 2 now active, not recruiting, …)
Show 5 sites
  • Orthopedic Associates of Hartford · Hartford, United StatesActive, not recruiting→Recruiting
  • Yale Center for Clinical Investigation, Yale School of Medicine · New Haven, United StatesRecruiting→Active, not recruiting
  • Foundation for Orthopaedic Research and Education · Tampa, United StatesRecruiting→Active, not recruiting
  • OrthoBethesda Research Foundation · Bethesda, United StatesActive, not recruiting→Completed
  • Texas Spine Consultants · Addison, United StatesNot yet recruiting→Recruiting
Show site
  • Michigan Orthopaedic Surgeons · Southfield, United States
Oct 28, 2026
Contact
Study contact changed: p•••@propharmagroup.com · •••0542→a•••@propharmagroup.com. See the current contact
Oct 28, 2026
Site contacts
Changed at 3 sites. See the sites
Show 3 sites
  • Orthopedic Associates of Hartford · Hartford, United StatesContact added B•••@hhchealth.orgContact added (no phone or email listed)
  • Yale Center for Clinical Investigation, Yale School of Medicine · New Haven, United StatesContact removed E•••@yale.edu · •••6591Contact removed m•••@yale.eduContact removed (no phone or email listed)
  • Foundation for Orthopaedic Research and Education · Tampa, United StatesContact removed d•••@foreonline.org · •••4263Contact removed (no phone or email listed)
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    1 site added. 5 sites changed recruiting status (2 now recruiting, 2 now active, not recruiting, …)
    Show 5 sites
    • Orthopedic Associates of Hartford · Hartford, United StatesActive, not recruiting→Recruiting
    • Yale Center for Clinical Investigation, Yale School of Medicine · New Haven, United StatesRecruiting→Active, not recruiting
    • Foundation for Orthopaedic Research and Education · Tampa, United StatesRecruiting→Active, not recruiting
    • OrthoBethesda Research Foundation · Bethesda, United StatesActive, not recruiting→Completed
    • Texas Spine Consultants · Addison, United StatesNot yet recruiting→Recruiting
    Show site
    • Michigan Orthopaedic Surgeons · Southfield, United States
    Contact Study contact changed: p•••@propharmagroup.com · •••0542→a•••@propharmagroup.com. See the current contact
    Site contacts Changed at 3 sites. See the sites
    Show 3 sites
    • Orthopedic Associates of Hartford · Hartford, United StatesContact added B•••@hhchealth.orgContact added (no phone or email listed)
    • Yale Center for Clinical Investigation, Yale School of Medicine · New Haven, United StatesContact removed E•••@yale.edu · •••6591Contact removed m•••@yale.eduContact removed (no phone or email listed)
    • Foundation for Orthopaedic Research and Education · Tampa, United StatesContact removed d•••@foreonline.org · •••4263Contact removed (no phone or email listed)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05329129
Lead sponsor
OssDsign
Responsible party
Sponsor
First posted
Apr 14, 2022
Start date
Mar 23, 2022
Primary completion
Mar 23, 2030 (estimated)
Completion
Apr 1, 2030 (estimated)
Last update
Oct 28, 2026

Study contacts

jeff Feldhaus
Contact
jfeldhaus@msquaredassociates.com
13476694903
Melanie Marshall
study director · OssDsign

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion